3 French Bioentrepreneurs are Awarded for Being Stubborn

07/01/2016 - 3 minutes

Building a company is extremely difficult and obstination is sometimes needed to reach success. The organisation, France Biotech, has given a price to the founder of Innate-Pharma, OSE Pharma and Effimune for their respective success. Why?

From left to right, Hervé Brailly, CEO & Founder of Innate-Pharma, Denis Lucquin, Managing Director of Sofinnova Partners, Maryvonne Hiance, Founder & CEO Effimune, and Dominique Costantini, Founder & CEO OSE Pharma. Here’s a short profile for each of these French biotech companies, which have vast expertise in Immunotherapies for a range of indications.

ose_pharma_effimmune_innate_pharma_france_biotech_stubborn_award

Hervé Brailly – Innate Pharma

Innate-Pharma is a successful immune-oncology Biotech company based in Marseille, in the South of France. It counts 112 employees and is developing the next generation of monoclonal antibodies against cancer. It has signed massive deals with BMS, Novo-Nordisk and more recently, AstraZeneca.

I visited the company in 2012 during our first documentary in France and I was impressed by its campus in the middle of the “

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT Do you want to remove this advert? Become a member!
ADVERTISEMENT Do you want to remove this advert? Become a member!

Support Us

Become a Member